Richard D. Pilnik - Aug 16, 2021 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Amy Culbert, attorney-in-fact
Stock symbol
DMAC
Transactions as of
Aug 16, 2021
Transactions value $
$49,064
Form type
4
Date filed
8/17/2021, 04:05 PM
Previous filing
Jul 16, 2021
Next filing
Jan 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMAC Voting Common Shares, no par value per share Purchase $8.03K +2.5K +3.1% $3.21 83.1K Aug 16, 2021 Direct F1
transaction DMAC Voting Common Shares, no par value per share Purchase $41K +12.5K +15.05% $3.28 95.6K Aug 16, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 19,887 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.